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Abstract
Background: Mounting evidence suggests that nutritional exposures during pregnancy
influence the fetal epigenome, and that these epigenetic changes can persist postnatally,
with implications for disease risk across the life course.
Methods:We review human intergenerational studies using a three-part search strategy.
Search 1 investigates associations between preconceptional or pregnancy nutritional
exposures, focusing on one-carbon metabolism, and offspring DNA methylation. Search
2 considers associations between offspring DNA methylation at genes found in the first
search and growth-related, cardiometabolic and cognitive outcomes. Search 3 isolates
those studies explicitly linking maternal nutritional exposure to offspring phenotype via
DNA methylation. Finally, we compile all candidate genes and regions of interest identi-
fied in the searches and describe their genomic locations, annotations and coverage on
the Illumina Infinium Methylation beadchip arrays.
VC The Author(s) 2018. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
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Results:We summarize findings from the 34 studies found in the first search, the 31 stud-
ies found in the second search and the eight studies found in the third search. We pro-
vide details of all regions of interest within 45 genes captured by this review.
Conclusions: Many studies have investigated imprinted genes as priority loci, but with
the adoption of microarray-based platforms other candidate genes and gene classes are
now emerging. Despite a wealth of information, the current literature is characterized by
heterogeneous exposures and outcomes, and mostly comprise observational associa-
tions that are frequently underpowered. The synthesis of current knowledge provided by
this review identifies research needs on the pathway to developing possible early life
interventions to optimize lifelong health.
Key words: Epigenetics, DNA methylation, fetal programming, Developmental Origins of Health and Disease, one-
carbon metabolism, candidate genes, metastable epialleles, cognitive development, cardiometabolic outcomes,
growth
Introduction
Epigenetic modifications influence gene expression without al-
tering the nucleotide sequence, through the action of a diverse
array of molecular mechanisms including DNA methylation,
histone modifications and RNA-mediated effects.1 Epigenetic
processes have been implicated in the aetiology of a variety of
diseases,2 most prominently cancer3 and fetal growth disor-
ders.4 Epigenetic marks are mitotically heritable and can be
influenced by the environment,5 suggesting a potential mecha-
nism linking early life exposures to later phenotype,6,7 a no-
tion supported by animal studies.8–10 However, the extent to
which epigenetics plays a role in fetal programming in humans
remains relatively unexplored. In this review we collate evi-
dence from human intergenerational studies, exploring which
nutritional exposures during pregnancy may affect DNA
methylation in the offspring, and the possible impact of such
modifications on health and disease risk across the life course.
DNA methylation and gene expression
Many biological processes rely on DNA methylation, in-
cluding genomic imprinting, X-chromosome inactivation
and tissue-specific gene expression.11 DNA methylation
describes the addition of a methyl group to a cytosine base
at the 5’ carbon position to form 5-methylcytosine,
catalyzed by DNA methyltransferases (DNMTs). This
most commonly occurs at cytosine bases adjacent to gua-
nine, termed CpG (‘cytosine-phosphate-guanine’) sites.
Regions of high CpG density are known as ‘CpG islands’,
and approximately two-thirds of human genes contain
these in their promoter regions.12 DNA methylation has
been shown to influence transcriptional activity either by
blocking transcription factors binding to the DNA, or by
the recruitment of histone modifiers which promote a
closed chromatin structure and gene silencing.1 CpG meth-
ylation within promoters is typically associated with tran-
scriptional silencing,13 although not consistently, and the
effect of DNA methylation may vary depending on which
region within the gene is methylated.14 There is also in-
creasing evidence that DNA methylation and histone mod-
ifications work in concert with non-coding RNAs to
regulate gene expression.15 DNA methylation plays a role
in chromatin remodelling, as DNMT enzymes at CpG sites
can be physically linked to enzymes which bring about his-
tone methylation and de-acetylation.13 MicroRNAs
(miRNAs) affect gene expression through binding to mes-
senger RNAs (mRNAs) and repressing translation,16 in-
cluding mRNAs that control the expression of DNMTs
Key Messages
• The body of evidence linking maternal nutritional exposure to offspring phenotype via DNA methylation in humans is
rapidly growing yet currently remains complex and inconsistent.
• Candidate genes in the field of intergenerational nutritional epigenetics go beyond imprinted genes to include other
gene classes such as metastable epialleles.
• Going forwards, there is a continued need for adequately powered prospective cohort studies with repeated longitu-
dinal measurements and randomized nutritional interventions to track the full continuum from maternal exposure to
offspring epigenotype to later phenotype.
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and histone deacetylases.15 The transcription of some
miRNA classes can be influenced by CpG methylation and
histone modifications.16
Epigenetics, windows of plasticity and the
Developmental Origins of Health and Disease
The Developmental Origins of Health and Disease (DOHaD)
hypothesis posits that early life exposure to environmental
insults can increase the risk of later adverse health outcomes.7
David Barker’s early cohort studies showed that lower birth-
weight was associated with an increased risk of hypertension,
type 2 diabetes (T2D) and cardiovascular disease in later
life,17 findings that were widely replicated.18 Risk of disease
was further exacerbated by rapid childhood weight gain,
adult obesity and other lifestyle factors such as unhealthy
diets, smoking and lack of exercise.19,20 The Dutch Hunger
Winter studies showed that exposure to famine during preg-
nancy was associated with a wide range of phenotypes in the
adult offspring, including increased blood pressure,21
obesity22 and schizophrenia,23 effects that depended on the
timing of the exposure during pregnancy.22
Epigenetic processes are emerging as potential mecha-
nisms to explain these and other associations found in the
DOHaD literature. For example the ‘thrifty epigenome’
hypothesis proposes that in utero exposures can shape an
epigenetic signature, resulting in a phenotype that is
‘adapted’ to the early life environment but which may
prove to be ‘maladapted’ if the environment changes in
later life.24 Therefore famine exposure during pregnancy
could programme ‘thrifty epigenotypes’ that are adapted
to a nutritionally poor environment, but this may subse-
quently trigger metabolic disease if the adult environment
changes to one that is nutritionally abundant.
The periconceptional period is a time of rapid cell dif-
ferentiation and epigenetic remodelling, and may therefore
represent a critical window during which the developing
epigenome is sensitive to environmental influences.25 We
define the periconceptional window from 14 weeks pre-
ceding conception until 10 weeks after conception.26
Within 48 hours of fertilization, there is rapid erasure of
methylation marks to render the developing cells pluripo-
tent.11 After implantation, re-methylation occurs in a
tissue-specific manner, and continues throughout preg-
nancy, enabling differentiation of somatic cells. A second
wave of demethylation occurs in the primordial germ cells
as they migrate to the genital ridge.27 At this stage most pa-
rental imprints are erased, so that sex-specific imprints can
be laid down. In boys the prospermatogonia then undergo
re-methylation throughout gestation, whereas in girls the
oocytes continue to be re-methylated over the duration of
their maturation, with evidence of high activity as each egg
ripens before ovulation.27
Notable classes of loci that may be especially sensitive
to early environmental exposure include imprinted genes,
metastable epialleles (MEs) and transposable elements
(TEs).6 Imprinted genes exhibit monoallelic expression,
whereby only the maternally or paternally inherited allele
is expressed, with expression controlled by regulatory
regions whose methylation state is inherited in a parent of
origin-specific manner.28 MEs are genomic loci showing
variable methylation between individuals, but showing
high correlation in methylation status across tissues within
the same individual, indicating establishment of methyla-
tion state in the first few days after conception, preceding
gastrulation.29 MEs therefore help to pinpoint the timing
of an exposure influencing ME methylation to the pericon-
ceptional period.30,31 TEs are small, mobile sequences of
DNA that are thought to comprise 45% of the human ge-
nome.32 They can insert into new genomic locations and
become disruptive if transposed into a functional gene or
when increasing copy number. Whereas most TEs are si-
lenced epigenetically,33 some have variable methylation
patterns that have been shown to be influenced by nutri-
tion in mice.9 Their methylation states can alter neighbour-
ing gene expression, exemplified by the Agouti mouse
model detailed later.
Influence of nutrition on DNA methylation
A range of maternal exposures have been associated with
DNA methylation including nutrition, stress, infection,
pollutants, smoking, radiation, level of exercise and paren-
tal body composition.34–36 Animal studies suggest that the
epigenome is particularly sensitive to such environmental
factors in early life, notably during the prenatal and neona-
tal periods.9,25,37 Studies of the effects of early life nutri-
tion on DNA methylation have shown that maternal
under- or over-nutrition or differences in protein, fat, sugar
or micronutrient intake during gestation can induce epige-
netic and phenotypic changes in the offspring.8,38 Recent
studies have also shown that variations in paternal diet or
body composition might also induce long-term epigenetic
and phenotypic changes in the offspring.39 One-carbon
nutrients and metabolites are thought to be particularly
important in the periconceptional period and during em-
bryonic development.26 One-carbon metabolism (OCM)
pathways link the folate, methionine, homocysteine, trans-
sulphuration and transmethylation metabolic pathways to-
gether (Figure 1) . These are crucial for many biochemical
processes, including DNA methylation.
Nutrition plays a key role in OCM by providing sub-
strates (folate, methionine, choline and betaine) and essen-
tial co-factors (vitamins B12, B6 and B2). For example,
B12 is required by methionine synthase to methylate
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homocysteine, B6 is essential in the homocysteine trans-
sulphuration pathway, and both B6 and B2 are needed to
reduce dietary folate to methyltetrahydrofolate. A more
detailed overview of OCM and the role of nutrients in
these pathways is provided in Supplementary Material 1,
available as Supplementary data at IJE online.
The potential for maternal nutrition to both alter off-
spring DNA methylation and influence phenotype is fa-
mously illustrated by the Agouti mouse experiments. Two
groups of pregnant dams were fed diets that differed only in
nutrients essential to OCM (folic acid, choline, betaine and
B12). Increased levels of one-carbon nutrients increased
methylation in the isogenic pups at a retrotransposon locus
[Intracisternal A Particle (IAP), also an ME] upstream of the
Agouti gene. The degree of expression of the Agouti gene
depended on the level of IAP methylation, and this in turn
altered the pups’ fur colour, as well as their appetite, adipos-
ity and glucose tolerance in adulthood.6,9
Review methodology
We performed a narrative review of the literature in three
stages to form the thematic analysis in this paper. First we
searched for studies describing associations between pre-
conceptional or pregnancy nutritional exposures and DNA
methylation in offspring. We limited this search to human
studies that used an intergenerational design. We included
nutritional exposures in dietary or supplemental form re-
lated to OCM, or broader measures that could influence
availability of such nutrients (famine, seasonal diets and
macronutrients). We excluded paternal exposures and
nutrients not directly involved in OCM, and we only con-
sidered epigenetic studies focusing on DNA methylation.
Second, we searched for human studies linking infant
DNA methylation to a subset of phenotypic outcomes
(growth-related, cardiometabolic and cognitive), restrict-
ing the included studies to those describing methylation at
Figure 1. A simplified summary of one-carbon metabolism. BHMT, Betaine Homocysteine MethylTransferase; CBS, Cystathionine-Beta-Synthase;
CTH, Cystathionine Gamma-Lyase; DHFR, Dihydrofolate Reductase; dTMP, Deoxythymidine Monophosphate; dTTP, Deoxythymidine Triphosphate;
FAD, Flavin Adenine Dinucleotide; GNMT, Glycine N-MethylTransferase; MAT, Methionine AdenosylTransferase; MS, Methionine Synthase; MT,
Methyl Transferases; MTHFD, MethyleneTetraHydroFolate Dehydrogenase; MTHF, MethyleneTetraHydroFolate Reductase; SAHH, S-Adenosyl
Homocysteine Hydrolase; SHMT, Serine HydroxyMethylTransferase; TS, Thymidylate Synthase. Source: reproduced with permission from James
et al. Epigenetics, nutrition and infant health. In: Karakochuk C, Whitfield K, Green T, Kraemer K (eds). The Biology of the First 1000 Days. Boca Raton,
FL: CRC Press, 2017.
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genetic loci identified in the first search (‘nutrition-
sensitive’ loci). Third, we isolated those studies explicitly
linking maternal nutritional exposure to offspring pheno-
type via DNA methylation. Three authors (P.J., S.S.,
A.S.T.) performed the searches in PubMed and Google
Scholar, assessing titles and abstracts against the
inclusion criteria. Reference sections of included studies
and relevant review papers were also used to help confirm
that key studies had been included. Searches took place
from January to March 2017. Supplementary Material 2,
available as Supplementary data at IJE online, details the
strategy and gives an example of the search terms used in
PubMed.
Review of studies linking maternal
nutritional exposure to offspring DNA
methylation
We provide a broad overview of the associations found in
the literature between maternal nutritional exposure and off-
spring DNA methylation in Table 1. Below we briefly review
the associations by type of exposure, but refer the reader to
detailed information on the individual studies (n ¼ 34) in
Supplementary Table 1, available as Supplementary data at
IJE online, which includes information on the nutritional
exposures, timing of exposures, study design, DNA tissue,
age of offspring and associated genes. All gene names are de-
fined in Table 4 (see candidate gene data summary, below).
Table 1. Summary of associations between maternal one-carbon metabolites and broader nutritional exposures with offspring
DNA methylation
Timing of exposure Maternal exposurea Offspring DNA methylation association
("/#: increased/decreased methylation)
Periconception "B2 "PLAGL1 (ZAC1),40 "VTRNA2-141
"Betaine " DNMT1,42 "POMC,43 "RXRA44
Famine #IGF2,45 "#bIGF2,46 #INSIGF,46,47 "IL10,47 "GNASAS,47 "LEP,47
"ABCA1,47 "MEG3,47 "TACC1,48 "ZNF385A,48 #TMEM105,48
"PAX8,49 #ZFP57,4, #PRDM949
"Folates #STX11,50 #OTX2,50 #TFAP2A,50 #CYS1,50 #LEP,44 "RXRA44
"Folic acid "LEP,42 #H19,51 "IGF2,52#IGF244
"Multiple micronutrients #GNASAS,53 #MEG3,53 #IGF2R,53 #MEST53
Seasonality of one-carbon
metabolitesc
"POMC,43 "VTRNA2-1,41 "BOLA3,30 "FLJ20433,30 "PAX8,30
"SLITRK1,30 "ZFYVE28,30 "RBM4631
1st and 2nd trimester "B6 "MEG354
"Betaine # LEP42
"Carbohydrates #RXRA55
"Choline #DNMT142
Famine "FAM150B,48 "SLC38A2,48 "PPAP2C,48 #OSBPL5/MRGPRG,48
"TACC1,48 "ZNF385A,48 "PAX8,49 #ZFP57,49 #PRDM949
"Folates #PEG3,56 "NR3C1,57 #MEG3,56 #PLAGL1,56 "IGF2,56 #LEP,42
#DNMT142
"Folic acid #PEG3,58 "IGF2,58 #DNMT144
3rd trimester "B2 "PLAGL1 (ZAC1)40
"B12 #IGF259
"Choline "#d NR3C1,60 "#dCRH,60 "DNMT1,42,44
Famine #GNASAS,47 "TACC1,48 "ZNF385A,48 "PAX8,49 #ZFP57,49
#PRDM949
"Folates "DNMT1,44 #RXRA,42 "LASP1,61 "ACADM,61 "WNT9A,61
"FZD7,61 #ZFP57,61 #LY6E,61 #C21orf5661
"Folic acid "RXRA42
" Meat and fish intake "HSD262
" High sugar, high fat diet "IGF263
"Omega-3 PUFA #H19,64 "IGF2,6 mostly #associations in EWAS65
"Omega-6 PUFA #MIRLET7BHG66
aLike nutrients are shaded in the same colour during each time period.
bDifferent associations at different loci within gene.
cRainy season (higher concentration of most one-carbon metabolites) versus dry season.
dDifferent associations between different tissues.
EWAS, epigenome-wide association study; PUFA, polyunsaturated fatty acids.
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Folate
Associations between maternal folate exposure and the off-
spring methylome are inconsistent, with varying effects
according to the form of folate (dietary folates or folic acid
supplements)58 the timing of exposure,42,58 baseline mater-
nal folate status,50,61 underlying genotype,67 the genomic
region affected68 and individual CpG site.42
Periconceptional folic acid has been positively associ-
ated with offspring methylation at LEP,42 inversely associ-
ated with methylation at H19,51 and has demonstrated
both positive52 and inverse44 associations at IGF2. Not all
studies have found an effect of periconceptional folic acid
exposure.58 Supplementation started after 12 weeks of ges-
tation has been associated with increased offspring methyl-
ation at IGF2 and decreased methylation at PEG3.58 Folic
acid taken up to the end of the second trimester has been
inversely associated with DNMT1 methylation, but posi-
tively correlated at the same locus when the folic acid con-
sumption was extended into the third trimester.44
Data for dietary folate intakes (assessed using questionnaires
or plasma samples) are equally variable. Periconceptional folate
intake and offspring DNA methylation were inversely associ-
ated with the majority of differentially methylated CpGs in an
epigenome-wide screen, although this trend reversed in strati-
fied analysis among women with low intakes (<200 mg/day).50
Periconceptional intakes have also been inversely associated
with methylation at LEP and positively associated at RXRA.44
First trimester folate exposure has shown positive associations
with DNA methylation at IGF256 and NR3C1,57 and inverse
associations at MEG3, PLAGL1 and PEG3.56 For second tri-
mester folate exposure, studies have reported inverse associa-
tions at multiple differentially methylated CpG sites,68 and at
LEP and DNMT1.42 Third trimester folate exposure has
shown positive associations with methylation at DNMT1,44
and at LASP1, ACADM, WNT9A, C21orf56 and FZD7,61
but inverse associations atZFP57, LY6E and RXRA.42,61
B vitamins
Maternal serum B12 at first antenatal visit has been in-
versely associated with cord blood global methylation lev-
els,67 and inversely associated with offspring IGF2
methylation when exposure timing was at delivery.59 Some
studies have assessed joint effects of B vitamins. One study
assessed pre-pregnancy and third trimester maternal B2,
B3, B6, folate and B12 intake, and found a positive corre-
lation between maternal B2 and offspring methylation at
PLAGL1 (ZAC1) at both time points.40 Another study
found no associations between first trimester maternal
plasma B12 and B6 concentrations with offspring methyla-
tion at H19, PEG10/SGCE and PLAGL1, but there was a
positive trend in methylation at MEG3 across maternal B6
quartiles.54
Choline and betaine
To date there is one human intervention study investigating
the effect of supplementing mothers’ diets with choline
(480mg vs 930mg) in the third trimester on offspring DNA
methylation. The intervention increased methylation at
NR3C1 and CRH in fetal placental tissue but reduced methyl-
ation in cord blood. No effect was seen at GNAS-AS, IGF2,
IL10 or LEP.60 In observational studies, second trimester cho-
line intake has been inversely associated withDNMT1methyl-
ation in cord blood.42 Third trimester choline intake has been
positively associated with DNMT1 methylation in cord blood
and in infant buccal cells.42,44 Maternal periconceptional beta-
ine intake has been positively associated with cord blood
methylation at DNMT1, RXRA and POMC,42–44 and second
trimester intake inversely associated with LEP methylation.42
Polyunsaturated fatty acids
Polyunsaturated fatty acids (PUFAs) are thought to influ-
ence OCM by upregulating enzymes responsible for the
methylation of homocysteine to methionine and by directly
influencing demand for methyl groups via phosphatidylcho-
line (described in Supplementary Material 1, available as
Supplementary data at IJE online). There have been several
studies of PUFA supplementation in mothers. In one trial,
omega-3 PUFA supplementation in the second and third tri-
mesters showed no difference in the cord blood methylation
of various gene promoter sites, but the intervention in-
creased global methylation (LINE-1) in offspring of mothers
who smoked.69 It also decreased H19 methylation, and in-
creased IGF2 methylation in offspring of overweight moth-
ers.64 A more recent trial, also implemented in the second
and third trimesters, found omega-3 PUFA supplementation
was associated with 21 differentially methylated regions
(DMRs) at birth.65 These were predominantly hypomethy-
lated in the intervention group. However, not all omega-3
PUFA supplementations trials have demonstrated an effect
on methylation.70 Maternal plasma omega-6 PUFA concen-
trations in the third trimester have been inversely associated
with offspring MIRLET7BHG methylation.66
Broader nutrition measures: famine studies,
seasonal exposures, macronutrients
Several studies have used broader measures of maternal
nutritional exposure, such as famine, season of conception
and macronutrient intake. During the Dutch Famine of
1944, there was a large drop in all food intakes, with aver-
age energy intake reduced to 500–1000 kcal per day.71
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In follow-up studies of adults who were exposed to famine
in utero, exposure in early pregnancy (periconception and
up to 10 weeks of gestation) was associated with lower
methylation of INSIF and TMEM105, increased methyla-
tion at IL10, GNASAS, LEP, ABCA1, MEG3, TACC1
and ZNF385A, and both increased and decreased methyla-
tion at IGF2 depending on the loci within the gene.45–48
Not all these effects were seen in those exposed during late
gestation.45,48 In a candidate gene analysis of putative
metastable epialleles, offspring exposed to famine for at
least 7 months during gestation in Bangladesh had higher
methylation at PAX8 and lower methylation at PRDM9
and ZFP57, compared with unexposed controls.49
One study found an inverse association between mater-
nal second trimester carbohydrate intake and infant RXRA
methylation.55 Another study looked at the effect of a pre-
natal diet high in fat and sugar and found a positive associ-
ation with offspring IGF2 methylation.63 Higher
methylation at GR has been observed in infants of mothers
having higher meat/fish/vegetables and lower bread/potato
intake in late pregnancy (>20 weeks of gestation compared
with earlier in pregnancy) and increased infant methylation
at HSD2 has been associated with increased maternal meat
and fish intake in late pregnancy.62 In a pilot trial of peri-
conceptional multiple micronutrient supplementation
(UNIMMAP) for mothers, there were sex-specific effects
on infant methylation at IGF2R, GNASAS, MEG3 and
MEST.53 The difficulty of such studies, however, is that it
is not possible to know which nutrient deficits or imbalan-
ces caused the epigenetic effects. In The Gambia, where
season has marked effects on maternal diet and body
weight,72 children conceived in the rainy season had higher
methylation in peripheral blood lymphocytes at six MEs,
at VTRNA2–1 and at POMC compared with those con-
ceived in the dry season.31,41,43 This may reflect a role of
one-carbon-related nutrients; in the rainy season, maternal
periconceptional plasma showed higher concentrations of
folate, B2, methionine, betaine, S-adenosyl methionine
(SAM):S-adenosyl homocysteine (SAH) ratio and betai-
ne:dimethylglycine (DMG) ratio, and lower B12 and ho-
mocysteine, indicating higher methylation potential.
Aside from those considered above, the list of maternal
exposures associated with changes in infant DNA methyla-
tion continues to grow. These include further nutrition-
related exposures (e.g. dietary polyphenols,73 vitamin
D74,75 and vitamin A76) non-nutrition-related exposures
(e.g. maternal stress77 and toxin exposure78) and factors
that span the spectrum of nutrition and health-related con-
siderations (e.g. maternal hyperglycaemia,79 maternal
body mass index (BMI),80–82 intrauterine growth restric-
tion (IUGR),83–85 the microbiome86 and infection87). The
ongoing challenge is not only to identify relevant
exposures, but also to delineate the consequences for hu-
man health across the life course. It is to this latter point
that we now turn.
Review of studies linking
nutrition-associated DNA methylation
loci to health outcomes
In animal studies, nutritional exposures in pregnancy bring
about distinct phenotypic effects in offspring via epigenetic
mechanisms. Differential methylation of genes may induce
phenotypic variation by the modulation of gene expression
which may alter tissue structure, homeostatic control pro-
cesses and the activity of metabolic pathways.88 Often
cited examples include the effects of maternal methyl do-
nor supplementation on offspring coat colour and adipos-
ity in the Agouti mouse, and the development of the fertile
queen bee from genetically identical larvae by epigenetic si-
lencing of DNMT3, caused by preferential feeding of royal
jelly.9,89
In this section we focus on evidence provided by two
types of studies:
i. Those reporting associations between methylation at
the nutrition-sensitive epigenetic loci described above
and offspring phenotypes; these are summarized in
Table 2, with detailed information on all included stud-
ies (n ¼ 31) in Supplementary Table 2, available as
Supplementary data at IJE online;
ii. Those linking maternal nutrition exposure, infant DNA
methylation and offspring phenotypic effects in a single
study (n ¼ 8); these are summarized in Table 3.
We consider three broad categories of offspring pheno-
typic outcomes: growth and body composition, cardiome-
tabolic risk markers and cognitive function.
Growth and body composition
DNA methylation signatures in different tissues such as
cord and peripheral blood, placenta, subcutaneous and vis-
ceral adipose tissue and buccal cells have been associated
with growth outcomes such as size at birth (usually birth-
weight, with or without adjustment for gestational age),
child/adult adiposity and skeletal growth or bone size/qual-
ity (see Supplementary Table 2, available as Supplementary
data at IJE online).
Birth size: most studies investigating growth-related
phenotypes have analysed imprinted genes due to their
known role in fetal growth regulation.106 Chromosomal
region 11p15.5 contains two imprinting control regions
(ICRs): the H19/IGF2 (ICR1) and KCNQ1/CDKN1C
(ICR2) domains.107 Russell–Silver Syndrome (RSS, a
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disorder of impaired growth) is associated with hypomethy-
lation of ICR1 and hypermethylation of ICR2. Beckwith-
Wiedemann Syndrome (BWS, an over-growth disorder) is
associated with hypermethylation of ICR1 and hypomethy-
lation of ICR2.108 Some studies indicate that patients with
RSS and BWS exhibit abnormal methylation at multiple
Table 2. Summary of associations between methylation at nutrition-sensitive genetic loci and phenotypes
Direction of DNA methylation/locus Associated phenotype/direction Tissue analysed Age at methylation
measurement("/#: increased/decreased)
Birth size
"H19,56 "PLAGL1,56
#MEG3,56 #MIRLET7BHG,66
"IGF290
"Birthweight Cord blood Birth
"IGF2 DMR291 "Birthweight Placenta Birth
#IGF2,52 "HSD262 "Birthweight Peripheral blood 17 months,52 40 years62
"H19 ICR62 #Birth length Peripheral blood 40 years
"PLAGL140 "Estimated fetal weight at 32 weeks of
gestation
Cord blood Birth
"HSD262 #Neonatal ponderal index Peripheral blood 40 years
#IGF2 DMR0,83 "H1992 "Small for gestational age Cord blood Birth
"MEST,93 "LEP94 "Small for gestational age Placenta,93 cord blood94 Birth
#IGF2 DMR095 "Small for gestational age Peripheral blood 11 years
Anthropometric measures/adiposity
"PLAGL140 "Weight at age 1 year Cord blood Birth
"PLAGL140 "Body mass index (BMI) z-score at age 1 year Cord blood Birth
"IGF2 DMR291 "Height, head and thorax circumference at
birth
Placenta Birth
"POMC96 "Obesity at age 11 years Peripheral blood 11 years
"IGF2/H19 ICR97 #Early childhood head circumference Peripheral blood 1–10 years
"H19 ICR,62 "HSD262 "Weight in adulthood Peripheral blood 40 years
"H19 ICR,62 "HSD2,62
"NR3C1 exon 1C62
"Waist circumference in adulthood Peripheral blood 40 years
"POMC,43 "H19 ICR,62
"HSD2,62 "NR3C1
exon 1C,62 #LEP98
"BMI in adulthood Peripheral blood 48,43 40,62 34.798 years
"RXRA55 "Adiposity at age 9 years Cord blood Birth
#LEP99 "Obesity at age 10–15 years Saliva 10–15 years
#LEP100 "Obese subjects with insulin resistance at age
10-16 years
Peripheral blood 10–16 years
"IGF2/H19 ICR97 "Skinfold thickness and subcutaneous
adiposity at age 17 years
Peripheral blood 17 years
Skeletal growth and bone quality
#RXRA75 "Bone mineral content at age 4 years Cord blood Birth
Cardiometabolic outcomes
"LEP98 "Fasting low-density lipoproteincholesterol
levels in adulthood
Peripheral blood,
Subcutaneous adipose
tissue
34.7 years
"H19 ICR,62 # NR3C1 exon
1F,62 "HSD262
"Blood pressure in adulthood Peripheral blood 40 years
#LEP101 "High-density lipoprotein (HDL) profile Peripheral blood 17 months
"IGF2102 "Triglycerides (TG), "TG:HDL Peripheral blood 11.6 years
Cognitive outcomes
"IGF263 "Early onset conduct problem, attention-
deficit/hyperactivity disorder
Cord blood Birth
"NR3C1,103,104 #HSD2103,104 "Risk of being in a poorly regulated neurobe-
havioural profile
Placenta, Buccal cells Birth
"LEP105 "Lethargy and hypotonicity Placenta Birth
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gene loci.109 Differences in methylation at these loci have
also been associated with less extreme growth-related phe-
notypes. In a study of 50 French-Canadian mothers and
infants, 31% of variance in birthweight was attributed
jointly to differential IGF2/H19 methylation and genotype
of a particular IGF2/H19 polymorphism (rs2107425).91
The direction of association between methylation and birth-
weight, however, varies by study and tissue analysed.90,91
For example, hypomethylation at IGF2 DMRs have been
associated with both increased and decreased birth-
weight.52,83,90,95,110 Some studies have found no association
with birthweight.111 Further examples of the complex rela-
tionship between DNA methylation at various IGF2/H19
DMRs and infant growth phenotypes are detailed in
Supplementary Table 2, available as Supplementary data at
IJE online.
The paternally expressed imprinted gene MEST acts as
an inhibitor of human adipogenesis and is involved in skel-
etal muscle growth and development.112 In placenta, in-
creased methylation at the MEST transcription start site is
correlated with reduced gene expression and IUGR.93,113
Increased methylation at the paternally expressed
PLAGL1, which codes for a cell growth suppressor pro-
tein, is associated with higher birthweight and weight at 1
year of age.40
Some studies have associated other (non-imprinted)
genes with birth size. For example, small-for-gestational
age newborns had higher methylation at LEP in cord
blood than appropriate-for-gestational age infants.94
Methylation at CpGs within HSD11B2, which codes for
the enzyme responsible for catalyzing the conversion of
cortisol to inactive cortisone, has been inversely related to
newborn ponderal index in a cohort study.62
A small number of studies have investigated links be-
tween maternal nutrition, DNA methylation and newborn
size. One study found that higher maternal erythrocyte fo-
late levels in the first trimester were associated with de-
creased methylation in cord blood at MEG3, PLAGL1
and PEG3, and increased methylation at IGF2.56 Folate
concentration and methylation at five DMRs were posi-
tively associated with birthweight. The authors hypothe-
siszed that the association of folate with birthweight could
be mediated by differential methylation at MEG3, H19
and PLAGL1, with MEG3 contributing the strongest ef-
fect. Another cohort study found that higher maternal
plasma glucose and omega-6 PUFA concentrations in the
third trimester were associated with increased infant meth-
ylation at IGDCC4 and CACNA1G, and decreased meth-
ylation at MIRLET7BHG. These methylation patterns
were all associated with higher birthweight.66
Adiposity: a case-control study in Germany found that
obese adults (BMI>35 kg/m2) demonstrated lower
methylation at MEST than in controls (BMI<25 kg/m2),
and used a separate dataset to suggest that such outcomes
may be partially caused by intrauterine exposure to gesta-
tional diabetes mellitus.114 In obese boys from the USA, an
inverse association was reported between LEP methylation
in buccal DNA and BMI, waist circumference (as z-scores)
and percentage body fat.99 NR3C1 Exon 1 C methylation
has been positively associated with waist circumference
and BMI at age 40 years,62 and increased IGF2/H19 meth-
ylation has been associated with increased skinfold thick-
ness and subcutaneous adiposity at age 17 years.97
A number of studies have investigated maternal nutri-
tional exposure, DNA methylation and child adiposity.
POMC codes for melanocyte-stimulating hormone (MSH)
and is involved with leptin in the regulation of body
weight. POMC is an ME, and children conceived in the
dry season in The Gambia had lower DNA methylation at
a POMC variably methylated region (VMR) compared
with those conceived in the rainy season.43 POMC VMR
methylation influences POMC expression,96 and methyla-
tion at this locus in blood and MSH-positive neurons is as-
sociated with BMI and obesity in children and adults.43
Godfrey et al. (2011) found that lower carbohydrate intake
during early pregnancy was associated with increased um-
bilical cord tissue methylation at RXRA, which in turn
was associated with greater adiposity in the offspring at
9 years of age.55
Skeletal growth and bone quality: RXRA forms hetero-
dimers with vitamin D (and other nuclear) receptors, facili-
tating their role in the regulation of bone metabolism.115,116
Differential methylation of specific CpGs in RXRA in cord
blood DNA has been inversely associated with percentage
bone mineral content and bone mineral content adjusted for
body size, measured at age 4 years, and also with maternal
free 25(OH)-vitamin D index.75
Cardiometabolic outcomes
Maternal nutritional status during pregnancy and factors
influencing fetal growth have been implicated in the aetiol-
ogy of cardiometabolic outcomes such as dyslipidaemia,
hypertension, type 2 diabetes (T2D) and cardiovascular
disease later in life.117,118
Leptin has been studied extensively in the domain of
cardiometabolic outcomes, owing to its role in metabolism
and regulation of body weight.119 LEP methylation at a
specific CpG in blood and subcutaneous adipose tissue has
been positively associated with low-density lipoprotein
cholesterol levels in very obese (BMI>40 kg/m2) adults.98
In the same study, methylation at the LEP promoter was
inversely correlated with BMI.98 A different study found
an inverse relationship between LEP methylation in whole
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blood and high-density lipoprotein cholesterol levels in 17-
month-old infants.101 Furthermore, lower methylation in
CpGs near the LEP transcription start site has been ob-
served in adolescents with obesity and insulin resistance,
although not with obesity alone.100 IGF2 methylation has
also been related to lipid profile in obese children aged
11 years; those with intermediate methylation at the IGF2
P3 promoter had higher triglycerides (TG) and a higher
TG:high-density lipoprotein cholesterol ratio than those
with hypomethylation.102 HSD2 methylation has been
positively associated with systolic blood pressure,62 and
NR3C1 exon1F and H19 ICR methylation also show posi-
tive associations with both systolic and diastolic blood
pressures in adults.62 Note that adiposity and obesity
(reviewed above) are also important risk factors that,
alongside other markers, can signal increased risk of ad-
verse cardiometabolic outcomes.120
Cognitive outcomes
The glucocorticoid receptors modulate the action of gluco-
corticoids and are involved in brain development and func-
tion.121 NR3C1 and HSD11B2 genes regulate the action
of cortisol and have been well studied in relation to neuro-
behaviour. Increased methylation at the NR3C1 promoter
and decreased methylation in HSD11B2 in placental and
infant buccal cell DNA have been associated with a high-
risk neurobehavioural profile characterized by poor atten-
tion, high excitability, low quality of movement and signs
of stress.103,104 An increase in LEP methylation in placen-
tal DNA has been associated with an increased risk of leth-
argy and hypotonia among male infants.105 Increased
methylation at IGF2 in cord blood has been associated
with early onset persistent attention-deficit/ hyperactivity
disorder (ADHD) in children between 7 and 13 years of
age.63
Candidate gene data summary
In Table 4 we provide further details of the 45 ‘candidate
genes’ highlighted so far in this review. This includes infor-
mation on their genomic location, the studies that consid-
ered them, regions of interest (ROIs) analysed and the
coverage of ROIs on Illumina Infinium Methylation bead-
chip arrays.
Discussion
In this review we have described evidence in humans link-
ing maternal nutrition during pregnancy with DNA meth-
ylation in the offspring, and linking DNA methylation at
nutrition-sensitive loci to phenotypes at birth and
outcomes in later life. As with all reviews, publication bias
can mean that null findings may have been under-reported,
and studies that do report associations may sometimes rely
on post hoc subgroup analyses for significant findings.
There are also numerous challenges specific to both the de-
sign and interpretation of intergenerational nutritional epi-
genetics studies which we discuss in the following sections.
Measuring nutritional exposures
Methods for measuring maternal nutritional exposure
have limitations. For example, one of the most commonly
used methods for this purpose are food frequency question-
naires, which suffer from recall bias and have differing va-
lidity by micronutrient.123 Weighed records require
accurate, context-specific dietary databases and well-
trained data collectors, and may not accurately reflect nor-
mal eating habits.124 However, these two approaches have
the advantage of capturing food groups and combinations
of nutrients that more direct tissue nutritional biomarkers
can overlook.125 Plasma biomarkers are challenging to in-
terpret, given that they represent nutrient levels after ab-
sorption and through interaction with genotype, and are
not simple reflections of dietary intake. Concentrations do
not capture metabolite flux, and can be misleadingly low if
tissue uptake is rapid. Of particular relevance to maternal
gestational samples is the effect of haemodilution, which
can lower several biomarker concentrations.126 Maternal
plasma nutrient concentrations are assumed to reflect die-
tary intake, and to correlate with cord blood concentra-
tions and nutrient levels in fetal tissue, which may not be
the case. Whereas positive correlations between maternal
serum and cord blood serum are found for homocysteine,
betaine, folate and B12, cord blood levels are multiple
times higher, suggesting that these nutrients are homeo-
statically controlled to ensure fetal supply.127 In the con-
text of periconceptional studies, more research is needed
on which accessible tissues best represent the nutritional
milieu surrounding the developing embryo in the initial
days after fertilization. In the meantime, serum or plasma
levels, though imperfect, are likely to offer a more accurate
representation of fetal nutrient exposure than dietary in-
take methods.
Most of the attention on nutritional exposures has
focused on the provision of methyl groups and the necessary
co-factors for DNA methylation. However, the periconcep-
tional period is marked by an initial wave of demethylation
to erase parental epigenetic marks, before the process of
remethylation.27 It is therefore important to consider the
role nutrition could play in influencing demethylation.
In demethylation, 5-methylcytosine is sequentially oxidized
to 5-hydroxymethylcytosine and 5-formylcytosine (5fC)
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by 10-11 translocation (TET) dioxygenases that use vitamin
C (ascorbate) as a co-factor.128 5fC can then either be fur-
ther oxidized to 5-carboxylcytosine or converted to an
unmethylated cytosine by base excision repair. Adding vita-
min C to mouse or human embryonic stem cells in vitro
increases the activity of TET enzymes, resulting in active de-
methylation in the germline.129 However, to our knowledge
there have been no human in vivo studies exploring effects
of periconceptional vitamin C deficiency on offspring DNA
methylation.
Nutritional compounds do not act in isolation, and ide-
ally analyses should recognize this by considering their inter-
actions in metabolic pathways. For example, one-carbon
metabolism is governed by intricately controlled feedback
loops which help protect the flux of metabolites, through
key reactions over a range of nutrient and co-factor concen-
trations.130,131 This means that associations between indi-
vidual micronutrients and methylation (e.g. the commonly
analysed methyl donors folate and betaine) can disappear
after adjustment for other metabolites (e.g. SAM and DMG,
which can inhibit transmethylation reaction rates).
Advances in measurement technology that allow the mea-
surement of a greater range of nutritional biomarkers (e.g.
metabolomics), combined with more sophisticated analyti-
cal techniques,132,133 should enable a more nuanced under-
standing of the ways in which nutritional biomarkers
combine to jointly influence methylation.
Measuring DNA methylation
A single CpG site in a single cell is either methylated or
unmethylated, but measurements are typically made at the
tissue level where methylation is a quantitative measure
corresponding to the proportion of methylated cells.134
Accurate assessment of tissue-level DNA methylation pat-
terns presents a challenge, given the sensitivity of the meas-
urements to both technical and biological variation. The
advent of high-throughput, genome-wide microarray plat-
forms, such as the Illumina HumanMethylation 450 K and
EPIC arrays,135–137 has helped in this regard, first by help-
ing to standardize aspects of epigenome-wide association
study (EWAS) design, and second by reducing the cost of
genome-wide methylation assays required for adequately
powered large studies.
Microarray-based EWAS have a number of limitations.
First, by design, only a small proportion of the methylome
is interrogated. These platforms attempt to include CpGs
sites from all annotated genes, but the number of CpG sites
per gene is low and equal coverage is typically not given to
all genomic features and/or CpG contexts, with the focus
having traditionally been on sites in promoters and CpG
islands. Second, arrays provide no information onT
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sequence-level variation, which is known to influence
methylation status.138,139 Finally, bioinformatics and ana-
lytical expertise are required (as well as the necessary com-
putational resources) to process and model the data, and to
correct for batch and other technical effects, in order to
obtain reliable, high-quality methylation profiles.140 As an
alternative, true genome-wide approaches such as whole-
genome bisulphite sequencing (WGBS) are available which
interrogate all 28 million CpG sites in the methylome, al-
though this is currently prohibitively expensive for larger
samples. Targeted high-resolution platforms141,142 offer a
potential compromise between coverage and cost, but their
utility, convenience and cost-effectiveness for performing
EWAS remain to be established. Given the importance of
demethylation during periconceptional epigenetic remodel-
ling, it may also be important to consider the oxidized
forms of 5-methyl cytosine (e.g. 5-hydroxymethylcytosine)
which occur as intermediate products in the demethylation
pathway.143
Tissue specificity, confounding and stability of
methylation across the life course
The tissue-specific nature of DNA methylation presents a
major challenge for epigenetic association studies.134,144
The majority of studies reported in this review are con-
strained to accessible tissues such as cord blood that may
be unrelated to the phenotype of interest, and different tis-
sues may be sensitive to different environmental exposures.
In this case reference epigenomes from different tissues and
cell types in both healthy and diseased individuals145 may
inform the choice of tissue as well as providing data for
investigating the tissue specificity of identified signals.
Where exposure-related effects occur during early embry-
onic development, before gastrulation, methylation
changes may be concordant across multiple tissues,146 so
that methylation states in accessible tissues such as blood
and buccal cells may serve as a proxy for methylation in
the target tissue.
Furthermore, numerous biological factors may act as
potential confounders, for example age, sex, smoking sta-
tus and BMI. Tissue-specific methylation differences aris-
ing from cell type heterogeneity, notably in blood, can also
act as confounders,147 although there are well-established
methods that can be used to correct for this.147,148
DNA sequence polymorphisms are also known to influ-
ence DNA methylation status and may confound observed
associations.149 Heritability of DNA methylation is esti-
mated to be in the range of 18% to 37%.150,151 Consistent
with this, many studies have shown that methylation quan-
titative trait loci (mQTL)—genetic variants associated with
methylation differences at the population level—are
widespread. To account for this, ideally high-throughput
genotype data on the sample being studied should be
used149 but, if such data are unavailable, population-level
reference mQTL data can be informative.139
Finally, methylation changes associated with an early-
life exposure may change throughout the life course, with
implications for their utility as biomarkers of exposure or
predictors of later phenotype.152–154 Depending on the re-
search question, this may suggest the need to assess long-
term stability of methylation at specific loci, through the
collection of longitudinal samples.
Linking methylation changes to gene function
Many of the DNA methylation changes reported in studies
covered in this review are small, often within the margins
of error of the measuring technology, making it difficult to
draw conclusions on their functional relevance.155 Indeed,
relatively few methylation studies measure gene expres-
sion. The link between DNA methylation and expression is
complex, depending on genomic context (e.g. location
with gene bodies, promoters and enhancers).156 This could
in part explain seemingly contradictory findings from dif-
ferent studies measuring associations at the same gene.
Moreover, a change in methylation may influence tran-
scription factor binding and the induction of a specific sig-
nalling pathway in order to observe a change in gene
expression. To aid further understanding, future studies
should therefore consider measuring transcription factor
binding, markers of gene transcription (mRNA levels),
and/or translation (protein levels), to better map the poten-
tial effects of DNA methylation differences on gene
function.157
Capturing phenotypes
In this review we have focused on phenotypic outcomes
most commonly considered in the DOHaD context.
However, we do not wish to exclude the possibility that
there may be a broader range of phenotypes that are impli-
cated. For example, exposure to the Dutch Hunger Winter
famine during pregnancy has been associated with a wide
variety of offspring phenotypes, varying according to the
timing of famine exposure during gestation.45,47
Consideration of the ‘thrifty epigenotype’ hypothesis24
would suggest that famine-imposed epigenetic modifica-
tions in early life are adaptive where similar environment
conditions persist, but maladaptive otherwise. There could
therefore be a spectrum of phenotypes according to how
great the mismatch is between in utero and later life envi-
ronments. In the case of complex traits such as obesity, the
resultant phenotype may also be influenced by factors such
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as diet and lifestyle in conjunction with methylation differ-
ences and genotype of the individual.158
Causal inference
A major goal of nutritional epigenetic studies, also covered
in this review, is to assess the potential for epigenetic
marks to mediate links between nutritional exposures and
health outcomes. In this context, the use of prospective
study designs with randomization including negative con-
trols, and techniques such as mediation analysis based on
regression systems,159 structural equation modelling160 or
network-based techniques,161 parametric/semi-parametric
methods,162 or instrumental variable approaches such as
Mendelian randomization,80,163,164 can help to strengthen
causal inference. More broadly, triangulating findings
from diverse studies, each with their own strengths, limita-
tions, assumptions and opposing biases, will maximize the
potential for robust findings.165,166
Study design considerations
The literature in this area is dominated by observational
studies. This increases the risk of spurious associations due
to confounding or reverse causation,149 the latter being a
particular problem with methylation association studies
where the direction of causality can be hard to establish.
Added to this, effect sizes are generally modest, with
group-level differences in mean methylation typically less
than 10% and often in the region of 1–5% for many of the
exposures and phenotypes studied.155,167,168 This has
implications for the design of studies characterizing
genome-wide, population-level methylation differences, as
they need to be adequately powered to detect potentially
small effects after adjusting for multiple testing.169
Current interest in periconceptional nutrition has stimu-
lated a number of preconceptional nutrition trials.170–174
In these studies, supplementation before conception is nec-
essary to ensure that the conception period is covered and
that a maximal effect on maternal nutritional status at con-
ception is achieved. Nonetheless, accurately pinpointing
the timing of nutritional exposures to conception is
challenging.
Conclusions
The body of evidence linking maternal nutritional exposure
to offspring phenotype via DNA methylation in humans is
rapidly growing yet currently remains complex and incon-
sistent. It is characterized by heterogeneous exposures and
outcomes, and mainly observational associations that are
frequently under-powered. Existing evidence suggests that
the effect of nutritional exposures on DNA methylation
depends on the form of the nutritional component, the tim-
ing of exposure during periconception and pregnancy, the
underlying nutritional status of the mother, maternal and
offspring genotype and the specific loci under investigation.
The picture is more complex than methylation being deter-
mined simply by availability of methyl donors. Many stud-
ies have investigated imprinted genes as priority loci for
their vulnerability to nutritional exposures, but with the
adoption of microarray-based platforms, other candidate
genes and gene classes are emerging, for example metastable
epialleles.
The utility of this emerging evidence in terms of its
translation into effective interventions and therapies
remains an open question. Epigenetic marks like DNA
methylation may act as integrators of multiple exposures
and genetic risk factors, as well as molecular mediators of
the effect of exposures on phenotype. Where robust associ-
ations are established, DNA methylation can serve as a
proxy measure or biomarker of earlier nutritional expo-
sures.175 As mediators of the effect on later phenotype, nu-
tritionally sensitive DNA methylation changes can provide
a means to identify genes and pathways for targeted inter-
ventions. Whereas there is still much work to do in this
area, there are grounds for optimism that epigenomic
approaches will provide insights into the molecular basis
of the developmental origins of health and disease, which
could in turn lead to the development of next-generation
interventions.
Supplementary data
Supplementary data are available at IJE online.
Funding
This work was supported by the Newton Fund initiative, jointly
funded by the Medical Research Council [MR/N006208/1], the
Department for International Development, UK, and the
Department of Biotechnology, Ministry of Science and Technology,
Government of India [BT/IN/DBT-MRC/ DFID/24/GRC/2015–16].
The funding bodies played no role in the design of the review, data
collection, analysis, interpretation of data or writing the manuscript.
The EMPHASIS study group includes
Lena Acolatse, MRC Unit The Gambia at the London
School of Hygiene and Tropical Medicine, The Gambia,
Meraj Ahmed, Genomic Research on Complex diseases
(GRC Group), CSIR-Centre for Cellular and Molecular
Biology, Hyderabad, India, Modupeh Betts, MRC Unit
The Gambia at the London School of Hygiene and
Tropical Medicine, The Gambia, Giriraj R Chandak,
22 International Journal of Epidemiology, 2018, Vol. 0, No. 0
Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyy153/5075855
by London School of Hygiene & Tropical Medicine user
on 28 August 2018
CSIR-Centre for Cellular and Molecular Biology,
Hyderabad, India, Harsha Chopra, Centre for the Study of
Social Change, Mumbai, India, Cyrus Cooper, MRC Life
Course Epidemiology Unit, University of Southampton,
UK, Momodou K Darboe, MRC Unit The Gambia at the
London School of Hygiene and Tropical Medicine, The
Gambia, Chiara Di Gravio, MRC Life Course
Epidemiology Unit, University of Southampton, UK,
Caroline HD Fall, MRC Life Course Epidemiology Unit,
University of Southampton, UK, Meera Gandhi, Centre for
the Study of Social Change, Mumbai, India, Gail R
Goldberg, MRC Elsie Widdowson Laboratory,
Cambridge, UK, Prachand Issarapu, Genomic Research on
Complex diseases (GRC Group), CSIR-Centre for Cellular
and Molecular Biology, Hyderabad, India, Philip James,
MRC Unit The Gambia at the London School of Hygiene
and Tropical Medicine, UK, Ramatoulie Janha, MRC Unit
The Gambia at the London School of Hygiene and
Tropical Medicine, The Gambia, Landing M A Jarjou,
MRC Unit The Gambia at the London School of Hygiene
and Tropical Medicine, The Gambia, Lovejeet Kaur,
Genomic Research on Complex diseases (GRC Group),
CSIR-Centre for Cellular and Molecular Biology,
Hyderabad, India, Sarah H Kehoe, MRC Life Course
Epidemiology Unit, University of Southampton, UK,
Kalyanaraman Kumaran, MRC Life Course Epidemiology
Unit, University of Southampton, UK and CSI Holdsworth
Memorial Hospital, Mysore, India, Karen A Lillycrop,
University of Southampton, UK, Mohammed Ngum, MRC
Unit The Gambia at the London School of Hygiene and
Tropical Medicine, The Gambia, Suraj S Nongmaithem,
Genomic Research on Complex diseases (GRC Group),
CSIR-Centre for Cellular and Molecular Biology,
Hyderabad, India, Stephen Owens, Institute of Health and
Society, Newcastle University, UK, Ramesh D Potdar,
Centre for the Study of Social Change, Mumbai, India,
Andrew M Prentice, MRC Unit The Gambia at the
London School of Hygiene and Tropical Medicine, The
Gambia, Ann Prentice, MRC Unit The Gambia, Elsie
Widdowson Laboratory, Cambridge, UK and MRC Life
Course Epidemiology Unit, University of Southampton,
UK, Tallapragada Divya Sri Priyanka, Genomic Research
on Complex diseases (GRC Group), CSIR-Centre for
Cellular and Molecular Biology, Hyderabad, India, Ayden
Saffari, MRC Unit The Gambia at the London School of
Hygiene and Tropical Medicine, UK, Sirazul Ameen
Sahariah, Centre for the Study of Social Change, Mumbai,
India, Sara Sajjadi, Genomic Research on Complex dis-
eases (GRC Group), CSIR-Centre for Cellular and
Molecular Biology, Hyderabad, India, Harshad Sane,
Centre for the Study of Social Change, Mumbai, India,
Smeeta Shrestha, Genomic Research on Complex diseases
(GRC Group), CSIR-Centre for Cellular and Molecular
Biology, Hyderabad, India, Matt J Silver, MRC Unit The
Gambia at the London School of Hygiene and Tropical
Medicine, UK, Ashutosh Singh Tomar, Genomic Research
on Complex diseases (GRC Group), CSIR-Centre for
Cellular and Molecular Biology, Hyderabad, India, Kate A
Ward, MRC Elsie Widdowson Laboratory, Cambridge
and MRC Life course Epidemiology Unit, University of
Southampton, UK, Dilip Kumar Yadav, Genomic Research
on Complex diseases (GRC Group), CSIR-Centre for
Cellular and Molecular Biology, Hyderabad, India,
Chittaranjan S Yajnik, Diabetes Unit, KEM Hospital and
Research Centre, Pune, India.
Conflict of interest: None declared.
References
1. Jaenisch R, Bird A. Epigenetic regulation of gene expression:
how the genome integrates intrinsic and environmental signals.
Nat Genet 2003;33(Suppl):245–54.
2. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human
disease and prospects for epigenetic therapy. Nature 2004;429:
457–63.
3. Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:
1148–59.
4. Moore GE, Ishida M, Demetriou C et al. The role and interac-
tion of imprinted genes in human fetal growth. Philos Trans R
Soc B Biol Sci 2015;370:20140074.
5. Bernstein BE, Meissner A, Lander ES. The mammalian epige-
nome.Cell 2007;128:669–81.
6. Waterland RA, Michels KB. Epigenetic epidemiology of the devel-
opmental origins hypothesis.Annu RevNutr 2007;27:363–88.
7. Burdge GC, Lillycrop KA. Nutrition, epigenetics, and develop-
mental plasticity: implications for understanding human dis-
ease. Annu Rev Nutr 2010;30:315–39.
8. Lillycrop KA, Burdge GC. Epigenetic mechanisms linking early
nutrition to long term health. Best Pract Res Clin Endocrinol
Metab 2012;26:667–76.
9. Waterland RA, Jirtle RL. Transposable elements: targets for
early nutritional effects on epigenetic gene regulation. Mol Cell
Biol 2003;23:5293–300.
10. Vickers MH. Early life nutrition, epigenetics and programming
of later life disease.Nutrients 2014;6:2165–78.
11. Messerschmidt DM, Knowles BB, Solter D. DNA methylation
dynamics during epigenetic reprogramming in the germline and
preimplantation embryos.Genes Dev 2014;28:812–28.
12. Wang Y, Leung FCC. An evaluation of new criteria for CpG
islands in the human genome as gene markers. Bioinformatics
2004;20:1170–77.
13. Klose RJ, Bird AP. Genomic DNA methylation: the mark and
its mediators. Trends Biochem Sci 2006;31:89–97.
14. Illingworth RS, Bird AP. CpG islands—‘a rough guide’. FEBS
Lett 2009;583:1713–20.
15. Guil S, Esteller M. DNA methylomes, histone codes and
miRNAs: tying it all together. Int J Biochem Cell Biol 2009;41:
87–95.
International Journal of Epidemiology, 2018, Vol. 0, No. 0 23
Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyy153/5075855
by London School of Hygiene & Tropical Medicine user
on 28 August 2018
16. Sato F, Tsuchiya S, Meltzer SJ, Shimizu K. MicroRNAs and epi-
genetics. FEBS J 2011;278:1598–609.
17. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME.
Growth in utero, blood pressure in childhood and adult life,
and mortality from cardiovascular disease. BMJ 1989;298:
564–67.
18. Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C,
Barker DJP. Catch-up growth in childhood and death from cor-
onary heart disease: longitudinal study. BMJ 1999;318:
427–31.
19. Barker DJP, Osmond C, Kajantie E, Eriksson JG. Growth and
chronic disease: findings in the Helsinki Birth Cohort. Ann
Hum Biol 2009;36:445–58.
20. Li Y, Ley SH, Tobias DK et al. Birth weight and later life adher-
ence to unhealthy lifestyles in predicting type 2 diabetes: pro-
spective cohort study. BMJ 2015;351:h3672.
21. Roseboom TJ, van der Meulen JH, van Montfrans GA et al.
Maternal nutrition during gestation and blood pressure in later
life. J Hypertens 2001;19:29–34.
22. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after
famine exposure in utero and early infancy. N Engl J Med
1976;295:349–53.
23. Susser E, Neugebauer R, Hoek HW et al. Schizophrenia after
prenatal famine.Arch Gen Psychiatry 1996;53:25–31.
24. Sto¨ger R. The thrifty epigenotype: an acquired and heritable
predisposition for obesity and diabetes? BioEssays 2008;30:
156–66.
25. Langley-Evans SC. Nutrition in early life and the programming
of adult disease: a review. J HumNutr Diet 2015;28:1–14.
26. Steegers-Theunissen RPM, Twigt J, Pestinger V, Sinclair KD.
The periconceptional period, reproduction and long-term
health of offspring: the importance of one-carbon metabolism.
HumReprod Update 2013;19:640–55.
27. Smallwood SA, Kelsey G. De novo DNA methylation: a germ
cell perspective. Trends Genet 2012;28:33–42.
28. Ishida M, Moore GE. The role of imprinted genes in humans.
Mol Aspects Med 2013;34:826–40.
29. Rakyan VK, Blewitt ME, Druker R, Preis JI, Whitelaw E.
Metastable epialleles in mammals. Trends Genet 2002;18:
348–51.
30. Waterland RA, Kellermayer R, Laritsky E et al. Season of con-
ception in rural Gambia affects DNA methylation at putative
human metastable epialleles. PLoS Genet 2010;6:e1001252.
31. Dominguez-Salas P, Moore SE, Baker MS et al. Maternal nutri-
tion at conception modulates DNA methylation of human
metastable epialleles.Nat Commun 2014;5:3746.
32. Hancks DC, Kazazian HH. Active human retrotransposons:
variation and disease. Curr Opin Genet Dev 2012;22:191–203.
33. Slotkin RK, Martienssen R. Transposable elements and the epi-
genetic regulation of the genome. Nat Rev Genet 2007;8:
272–85.
34. Perera F, Herbstman J. Prenatal environmental exposures, epi-
genetics, and disease. Reprod Toxicol 2011;31:363–73.
35. Reul JMHM, Collins A, Saliba RS et al. Glucocorticoids, epige-
netic control and stress resilience. Neurobiol Stress 2015;1:
44–59.
36. Fowden AL, Forhead AJ. Hormones as epigenetic signals in de-
velopmental programming. Exp Physiol 2009;94:607–25.
37. Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epige-
netics and methyl supplements affect agouti gene expression in
Avy/a mice. FASEB J 1998;12:949–57.
38. Jime´nez-Chillaro´n JC, Dı´az R, Martı´nez D et al. The role of nu-
trition on epigenetic modifications and their implications on
health. Biochimie 2012;94:2242–63.
39. Soubry A. Epigenetic inheritance and evolution: a paternal per-
spective on dietary influences. Prog Biophys Mol Biol 2015;
118:79–85.
40. Azzi S, Sas TCJ, Koudou Y et al. Degree of methylation of
ZAC1 (PLAGL1) is associated with prenatal and post-natal
growth in healthy infants of the EDEN mother child cohort.
Epigenetics 2014;9:338–45.
41. Silver MJ, Kessler NJ, Hennig BJ et al. Independent genome-
wide screens identify the tumor suppressor VTRNA2-1 as a hu-
man epiallele responsive to periconceptional environment.
Genome Biol 2015;16:118.
42. Pauwels S, Ghosh M, Duca RC et al. Dietary and supplemental
maternal methyl-group donor intake and cord blood DNA
methylation. Epigenetics 2017;12:1–10.
43. Ku¨hnen P, Handke D, Waterland RA et al. Interindividual vari-
ation in DNA methylation at a putative POMC metastable epi-
allele is associated with obesity.Cell Metab 2016;24:502–09.
44. Pauwels S, Ghosh M, Duca RC et al. Maternal intake of
methyl-group donors affects DNA methylation of metabolic
genes in infants. Clin Epigenetics 2017;9:16.
45. Heijmans BT, Tobi EW, Stein AD et al. Persistent epigenetic
differences associated with prenatal exposure to famine in
humans. Proc Natl Acad Sci USA 2008;105:17046–49.
46. Tobi EW, Slagboom PE, van Dongen J et al. Prenatal famine
and genetic variation are independently and additively associ-
ated with DNA methylation at regulatory loci within IGF2/
H19. PLoS One 2012;7:e37933.
47. Tobi EW, Lumey LH, Talens RP et al. DNA methylation differ-
ences after exposure to prenatal famine are common and tim-
ing- and sex-specific. HumMol Genet 2009;18:4046–53.
48. Tobi EW, Slieker RC, Stein AD et al. Early gestation as the criti-
cal time-window for changes in the prenatal environment to af-
fect the adult human blood methylome. Int J Epidemiol 2015;
44:1211–23.
49. Finer S, Iqbal MS, Lowe R et al. Is famine exposure during de-
velopmental life in rural Bangladesh associated with a meta-
bolic and epigenetic signature in young adulthood? A historical
cohort study. BMJOpen 2016;6:e011768.
50. Gonseth S, Roy R, Houseman EA et al. Periconceptional folate
consumption is associated with neonatal DNA methylation
modifications in neural crest regulatory and cancer develop-
ment genes. Epigenetics 2015;10:1166–76.
51. Hoyo C, Murtha AP, Schildkraut JM et al. Methylation varia-
tion at IGF2 differentially methylated regions and maternal fo-
lic acid use before and during pregnancy. Epigenetics 2011;6:
928–36.
52. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D et al.
Periconceptional maternal folic acid use of 400 microg per day
is related to increased methylation of the IGF2 gene in the very
young child. PLoSOne 2009;4:e7845.
53. Cooper WN, Khulan B, Owens S et al. DNA methylation profil-
ing at imprinted loci after periconceptional micronutrient
24 International Journal of Epidemiology, 2018, Vol. 0, No. 0
Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyy153/5075855
by London School of Hygiene & Tropical Medicine user
on 28 August 2018
supplementation in humans: results of a pilot randomized con-
trolled trial. FASEB J 2012;26:1782–90.
54. McCullough LE, Miller EE, Mendez MA, Murtha AP, Murphy
SK, Hoyo C. Maternal B vitamins: effects on offspring weight
and DNA methylation at genomically imprinted domains. Clin
Epigenetics 2016;8:8.
55. Godfrey KM, Sheppard A, Gluckman PD et al. Epigenetic gene
promoter methylation at birth is associated with child’s later
adiposity.Diabetes 2011;60:1528–34.
56. Hoyo C, Daltveit AK, Iversen E et al. Erythrocyte folate con-
centrations, CpG methylation at genomically imprinted
domains, and birth weight in a multiethnic newborn cohort.
Epigenetics 2014;9:1120–30.
57. van Mil NH, Bouwland-Both MI, Stolk L et al. Determinants
of maternal pregnancy one-carbon metabolism and newborn
human DNA methylation profiles. Reproduction 2014;148:
581–92.
58. Haggarty P, Hoad G, Campbell DM, Horgan GW, Piyathilake
C, McNeill G. Folate in pregnancy and imprinted gene and re-
peat element methylation in the offspring. Am J Clin Nutr
2013;97:94–99.
59. Ba Y, Yu H, Liu F et al. Relationship of folate, vitamin B12 and
methylation of insulin-like growth factor-II in maternal and
cord blood. Eur J Clin Nutr 2011;65:480–85.
60. Jiang X, Yan J, West AA et al. Maternal choline intake alters
the epigenetic state of fetal cortisol-regulating genes in humans.
FASEB J 2012;26:3563–74.
61. Amarasekera M, Martino D, Ashley S et al. Genome-wide
DNA methylation profiling identifies a folate-sensitive region
of differential methylation upstream of ZFP57-imprinting regu-
lator in humans. FASEB J 2014;28:4068–76.
62. Drake AJ, McPherson RC, Godfrey KM et al. An unbalanced
maternal diet in pregnancy associates with offspring epigenetic
changes in genes controlling glucocorticoid action and foetal
growth.Clin Endocrinol 2012;77:808–15.
63. Rijlaarsdam J, Cecil CAM, Walton E et al. Prenatal unhealthy diet,
insulin-like growth factor 2 gene (IGF2) methylation, and attention
deficit hyperactivity disorder symptoms in youth with early-onset
conduct problems. J Child Psychol Psychiatr 2017;58:19–27.
64. Lee H-S, Barraza-Villarreal A, Biessy C et al. Dietary supple-
mentation with polyunsaturated fatty acid during pregnancy
modulates DNA methylation at IGF2/H19 imprinted genes and
growth of infants. Physiol Genomics 2014;46:851–57.
65. Dijk SJ. V, Zhou J, Peters TJ et al. Effect of prenatal DHA sup-
plementation on the infant epigenome: results from a random-
ized controlled trial. Clin Epigenetics 2016;8:114.
66. Lin X, Lim IY, Wu Y et al. Developmental pathways to adipos-
ity begin before birth and are influenced by genotype, prenatal
environment and epigenome. BMCMed 2017;15:50.
67. McKay JA, Groom A, Potter C et al. Genetic and non-genetic
influences during pregnancy on infant global and site specific
DNA methylation: role for folate gene variants and vitamin
B12. PLoSOne 2012;7:e33290.
68. Joubert BR, Dekker HT. D, Felix JF et al. Maternal plasma fo-
late impacts differential DNA methylation in an epigenome-
wide meta-analysis of newborns. Nat Commun 2016;7:10577.
69. Lee H-S, Barraza-Villarreal A, Hernandez-Vargas H et al.
Modulation of DNA methylation states and infant immune
system by dietary supplementation with x-3 PUFA during preg-
nancy in an intervention study. Am J Clin Nutr 2013;98:
480–87.
70. Amarasekera M, Noakes P, Strickland D, Saffery R, Martino
DJ, Prescott SL. Epigenome-wide analysis of neonatal CD4 þ
T-cell DNA methylation sites potentially affected by maternal
fish oil supplementation. Epigenetics 2014;9:1570–76.
71. Lumey LH, Stein AD, Kahn HS et al. Cohort Profile: The Dutch
Hunger Winter families study. Int J Epidemiol 2007;36:
1196–204.
72. Prentice A, Whitehead R, Roberts S, Paul A. Long-term energy
balance in child-bearing Gambian women. Am J Clin Nutr
1981;34:2790–99.
73. Fang M, Chen D, Yang CS. Dietary polyphenols may affect
DNA methylation. J Nutr 2007;137(Suppl 1):223–28S.
74. Pereira F, Barba´chano A, Singh PK, Campbell MJ, Mu~noz A,
Larriba MJ. Vitamin D has wide regulatory effects on histone
demethylase genes. Cell Cycle 2012;11:1081–89.
75. Harvey NC, Sheppard A, Godfrey KM et al. Childhood bone
mineral content is associated with methylation status of the
RXRA promoter at birth. J BoneMiner Res 2014;29:600–07.
76. Feng Y, Zhao L-Z, Hong L, Shan C, Shi W, Cai W. Alteration
in methylation pattern of GATA-4 promoter region in vitamin
A-deficient offspring’s heart. J Nutr Biochem 2013;24:
1373–80.
77. Babenko O, Kovalchuk I, Metz GAS. Stress-induced perinatal
and transgenerational epigenetic programming of brain devel-
opment and mental health. Neurosci Biobehav Rev 2015;48:
70–91.
78. Anway MD, Skinner MK. Epigenetic transgenerational actions
of endocrine disruptors. Endocrinology 2006;147(Suppl 6):
S43–49.
79. Hajj NE, Schneider E, Lehnen H, Haaf T. Epigenetics and life-
long consequences of an adverse nutritional and diabetic intra-
uterine environment. Reproduction 2014;148:R111–20.
80. Sharp GC, Lawlor DA, Richmond RC et al. Maternal pre-
pregnancy BMI and gestational weight gain, offspring DNA
methylation and later offspring adiposity: findings from the
Avon Longitudinal Study of Parents and Children. Int J
Epidemiol 2015;44:1288–304.
81. Azzi S, Brioude F, Bouc YL, Netchine I. Human imprinting
anomalies in fetal and childhood growth disorders: clinical
implications and molecular mechanisms. Curr Pharm Des
2014;20:1751–63.
82. Burris HH, Baccarelli AA, Byun H-M et al. Offspring DNA
methylation of the aryl-hydrocarbon receptor repressor gene is
associated with maternal BMI, gestational age, and birth
weight. Epigenetics 2015;10:913–21.
83. Bouwland-Both MI, van Mil NH, Stolk L et al. DNA methyla-
tion of IGF2DMR and H19 is associated with fetal and infant
growth: the generation R study. PLoSOne 2013;8:e81731.
84. Einstein F, Thompson RF, Bhagat TD et al. Cytosine methyla-
tion dysregulation in neonates following intrauterine growth
restriction. PLoSOne 2010;5:e8887.
85. Toure DM, Baccaglini L, Opoku ST et al. Epigenetic dysregula-
tion of insulin-like growth factor (IGF)-related genes and ad-
verse pregnancy outcomes: a systematic review. J Matern Fetal
Neonatal Med 2016;18:1–11.
International Journal of Epidemiology, 2018, Vol. 0, No. 0 25
Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyy153/5075855
by London School of Hygiene & Tropical Medicine user
on 28 August 2018
86. Davie JR. Inhibition of histone deacetylase activity by butyrate.
J Nutr 2003;133(Suppl 7):2485–93S.
87. Claycombe KJ, Brissette CA, Ghribi O. Epigenetics of inflam-
mation, maternal infection, and nutrition. J Nutr 2015;145:
1109–15S.
88. Burdge GC, Hanson MA, Slater-Jefferies JL, Lillycrop KA.
Epigenetic regulation of transcription: a mechanism for induc-
ing variations in phenotype (fetal programming) by differences
in nutrition during early life? Br J Nutr 2007;97:1036.
89. Kucharski R, Maleszka J, Foret S, Maleszka R. Nutritional con-
trol of reproductive status in honeybees via DNA methylation.
Science 2008;319:1827.
90. Hoyo C, Fortner K, Murtha AP et al. Association of cord blood
methylation fractions at imprinted insulin-like growth factor 2
(IGF2), plasma IGF2, and birth weight. Cancer Causes Control
2012;23:635–45.
91. St-Pierre J, Hivert M-F, Perron P et al. IGF2 DNA methylation
is a modulator of newborn’s fetal growth and development.
Epigenetics 2012;7:1125–32.
92. Qian Y-Y, Huang X-L, Liang H et al. Effects of maternal folic
acid supplementation on gene methylation and being small for
gestational age. J HumNutr Diet 2016;29:643–51.
93. Kappil MA, Green BB, Armstrong DA et al. Placental expres-
sion profile of imprinted genes impacts birth weight.
Epigenetics 2015;10:842–49.
94. Lesseur C, Armstrong DA, Paquette AG, Koestler DC, Padbury
JF, Marsit CJ. Tissue-specific leptin promoter DNA methyla-
tion is associated with maternal and infant perinatal factors.
Mol Cell Endocrinol 2013;381:160–67.
95. Murphy R, Thompson JM, Tost J, Mitchell EA; Auckland
Birthweight Collaborative Study Group. No evidence for copy
number and methylation variation in H19 and KCNQ10T1 im-
printing control regions in children born small for gestational
age. BMCMed Genet 2014;15:67.
96. Kuehnen P, Mischke M, Wiegand S et al. An Alu element-
associated hypermethylation variant of the POMC gene is asso-
ciated with childhood obesity. PLoS Genet 2012;8:e1002543.
97. Huang R-C, Galati JC, Burrows S et al. DNA methylation of
the IGF2/H19 imprinting control region and adiposity distribu-
tion in young adults. Clin Epigenetics 2012;4:21.
98. Houde A-A, Le´gare´ C, Biron S et al. Leptin and adiponectin
DNA methylation levels in adipose tissues and blood cells are
associated with BMI, waist girth and LDL-cholesterol levels in
severely obese men and women. BMCMed Genet 2015;16:29.
99. Dunstan J, Bressler JP, Moran TH et al. Associations of LEP,
CRH, ICAM-1, and LINE-1 methylation, measured in saliva,
with waist circumference, body mass index, and percent body
fat in mid-childhood. Clin Epigenet 2017;9:29.
100. Garcı´a-Cardona MC, Huang F, Garcı´a-Vivas JM et al. DNA
methylation of leptin and adiponectin promoters in children is
reduced by the combined presence of obesity and insulin resis-
tance. Int J Obes 2014;38:1457–65.
101. Wijnands KPJ, Obermann-Borst SA, Steegers-Theunissen
RPM. Early life lipid profile and metabolic programming in
very young children. Nutr Metab Cardiovasc Dis 2015;25:
608–14.
102. Deodati A, Inzaghi E, Liguori A et al. IGF2 methylation is asso-
ciated with lipid profile in obese children. Horm Res Paediatr
2013;79:361–67.
103. Paquette AG, Lester BM, Lesseur C et al. Placental epigenetic
patterning of glucocorticoid response genes is associated with
infant neurodevelopment. Epigenomics 2015;7:767–79.
104. Lester BM, Marsit CJ, Giarraputo J, Hawes K, LaGasse LL,
Padbury JF. Neurobehavior related to epigenetic differences in
preterm infants. Epigenomics 2015;7:1123–36.
105. Lesseur C, Armstrong DA, Murphy MA et al. Sex-specific asso-
ciations between placental leptin promoter DNA methylation
and infant neurobehavior. Psychoneuroendocrinology 2014;
40:1–9.
106. Reik W, Walter J. Genomic imprinting: parental influence on
the genome.Nat Rev Genet 2001;2:21–32.
107. Nordin M, Bergman D, Halje M, Engstro¨m W, Ward A.
Epigenetic regulation of the Igf2/H19 gene cluster. Cell Prolif
2014;47:189–99.
108. Piedrahita JA. The role of imprinted genes in fetal growth ab-
normalities. Birth Defects Res Part A Clin Mol Teratol 2011;
91:682–92.
109. Azzi S, Rossignol S, Steunou V et al. Multilocus methylation
analysis in a large cohort of 11p15-related foetal growth disor-
ders (Russell Silver and Beckwith Wiedemann syndromes)
reveals simultaneous loss of methylation at paternal and mater-
nal imprinted loci. HumMol Genet 2009;18:4724–33.
110. Liu Y, Murphy SK, Murtha AP et al. Depression in pregnancy,
infant birth weight and DNA methylation of imprint regulatory
elements. Epigenetics 2012;7:735–46.
111. Tobi EW, Heijmans BT, Kremer D et al. DNA methylation of
IGF2, GNASAS, INSIGF and LEP and being born small for ges-
tational age. Epigenetics 2011;6:171–76.
112. Karbiener M, Glantschnig C, Pisani DF et al. Mesoderm-spe-
cific transcript (MEST) is a negative regulator of human adipo-
cyte differentiation. Int J Obes 2015;39:1733–41.
113. McMinn J, Wei M, Schupf N et al. Unbalanced placental ex-
pression of imprinted genes in human intrauterine growth re-
striction. Placenta 2006;27:540–49.
114. Hajj NE, Pliushch G, Schneider E et al. Metabolic program-
ming of MEST DNA methylation by intrauterine exposure to
gestational diabetes mellitus.Diabetes 2013;62:1320–28.
115. Ahuja HS, Szanto A, Nagy L, Davies PJA, The retinoid X recep-
tor and its ligands: versatile regulators of metabolic function,
cell differentiation and cell death. J Biol Regul Homeost Agents
2003;17:29–45.
116. Yee YK, Chintalacharuvu SR, Lu J, Nagpal S. Vitamin D recep-
tor modulators for inflammation and cancer. Mini Rev Med
Chem 2005;5:761–78.
117. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens
JA, Robinson JS. Fetal nutrition and cardiovascular disease in
adult life. Lancet 1993;341:938–41.
118. Barker DJP. Fetal growth and adult disease. Br J Obstet
Gynaecol 1992;99:275–76.
119. Vickers MH. Developmental programming and adult obesity:
the role of leptin. Curr Opin Endocrinol Diabetes Obes 2007;
14:17–22.
26 International Journal of Epidemiology, 2018, Vol. 0, No. 0
Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyy153/5075855
by London School of Hygiene & Tropical Medicine user
on 28 August 2018
120. Despre´s J-P, Lemieux I, Bergeron J et al. Abdominal obesity
and the metabolic syndrome: contribution to global cardiome-
tabolic risk. Arterioscler Thromb Vasc Biol 2008;28:1039.
121. Harris A, Seckl J. Glucocorticoids, prenatal stress and the pro-
gramming of disease.Horm Behav 2011;59:279–89.
122. Ara´nyi T, Tusna´dy GE. BiSearch: ePCR tool for native or
bisulfite-treated genomic template. Methods Mol Biol 2007;
402:385–402.
123. Kroke A, Klipstein-Grobusch K, Voss S et al. Validation of a
self-administered food-frequency questionnaire administered in
the European Prospective Investigation into Cancer and
Nutrition (EPIC) Study: comparison of energy, protein, and
macronutrient intakes estimated with the doubly labeled water,
urinary nitrogen, and repeated 24-h dietary recall methods. Am
J Clin Nutr 1999;70:439–47.
124. Black AE, Prentice AM, Goldberg GR et al. Measurements of
total energy expenditure provide insights into the validity of di-
etary measurements of energy intake. J Am Diet Assoc 1993;
93:572–79.
125. Biro´ G, Hulshof KFAM, Ovesen L, Amorim Cruz JA;
EFCOSUM Group. Selection of methodology to assess food in-
take. Eur J Clin Nutr 2002;56(Suppl 2):S25–32.
126. Faupel-Badger JM, Hsieh C-C, Troisi R, Lagiou P, Potischman
N. Plasma volume expansion in pregnancy: implications for
biomarkers in population studies. Cancer Epidemiol
Biomarkers Prev 2007;16:1720–23.
127. Wallace JM, Bonham MP, Strain J et al. Homocysteine concen-
tration, related B vitamins, and betaine in pregnant women
recruited to the Seychelles Child Development Study. Am J Clin
Nutr 2008;87:391–97.
128. Young JI, Zu¨chner S, Wang G. Regulation of the epigenome by
vitamin C. Annu Rev Nutr 2015;35:545–64.
129. Blaschke K, Ebata KT, Karimi MM et al. Vitamin C induces
Tet-dependent DNA demethylation and a blastocyst-like state
in ES cells. Nature 2013;500:222–26.
130. Reed MC, Gamble MV, Hall MN, Nijhout HF. Mathematical
analysis of the regulation of competing methyltransferases.
BMC Syst Biol 2015;9:69.
131. Nijhout HF, Best J, Reed MC. Escape from homeostasis. Math
Biosci 2014;257:104–10.
132. Aurich MK, Thiele I. Computational modeling of human me-
tabolism and its application to systems biomedicine. Methods
Mol Biol 2016;1386:253–81.
133. Thiele I, Swainston N, Fleming RMT et al. A community-
driven global reconstruction of human metabolism. Nat
Biotechnol 2013;31:419–25.
134. Michels KB, Binder AM, Dedeurwaerder S et al.
Recommendations for the design and analysis of epigenome-
wide association studies. Nat Methods 2013;10:949–55.
135. Bibikova M, Le J, Barnes B et al. Genome-wide DNA methyla-
tion profiling using InfiniumV
R
assay. Epigenomics 2009;1:
177–200.
136. Bibikova M, Barnes B, Tsan C et al. High density DNA methyl-
ation array with single CpG site resolution. Genomics 2011;98:
288–95.
137. Pidsley R, Zotenko E, Peters TJ et al. Critical evaluation of the
Illumina MethylationEPIC BeadChip microarray for whole-
genome DNA methylation profiling.Genome Biol 2016;17:208.
138. Wagner JR, Busche S, Ge B, Kwan T, Pastinen T, Blanchette M.
The relationship between DNA methylation, genetic and ex-
pression inter-individual variation in untransformed human
fibroblasts. Genome Biol 2014;15:R37.
139. Gaunt TR, Shihab HA, Hemani G et al. Systematic identifica-
tion of genetic influences on methylation across the human life
course. Genome Biol 2016;17:61.
140. Morris TJ, Beck S. Analysis pipelines and packages for Infinium
HumanMethylation450 BeadChip (450k) data. Methods 2015;
72:3–8.
141. Li Q, Suzuki M, Wendt J et al. Post-conversion targeted capture
of modified cytosines in mammalian and plant genomes.
Nucleic Acids Res 2015;43:e81.
142. Teh AL, Pan H, Lin X et al. Comparison of methyl-capture se-
quencing vs. infinium 450K methylation array for methylome
analysis in clinical samples. Epigenetics 2016;11:36–48.
143. Ulahannan N, Greally JM. Genome-wide assays that identify
and quantify modified cytosines in human disease studies.
Epigenetics Chromatin 2015;8:5.
144. Roadmap Epigenomics Consortium: Kundaje A, Meuleman W,
Ernst J et al. Integrative analysis of 111 reference human epige-
nomes. Nature 2015;518:317–30.
145. Bujold D, Morais DAL, Gauthier C et al. The international hu-
man epigenome consortium data portal. Cell Syst 2016;3:
496–99.e2.
146. van Baak TE, Coarfa C, Dugue´ PA et al. Epigenetic supersimi-
larity of monozygotic twin pairs.Genome Biol 2018;19:2.
147. Jaffe AE, Irizarry RA. Accounting for cellular heterogeneity is
critical in epigenome-wide association studies. Genome Biol
2014;15:R31.
148. Houseman EA, Accomando WP, Koestler DC et al. DNA meth-
ylation arrays as surrogate measures of cell mixture distribu-
tion. BMCBioinformatics 2012;13:86.
149. Birney E, Davey Smith G, Greally JM. Epigenome-wide associ-
ation studies and the interpretation of disease -omics. PLoS
Genet 2016;12:e1006105.
150. Bell JT, Tsai PC, Yang TP et al. Epigenome-wide scans identify
differentially methylated regions for age and age-related pheno-
types in a healthy ageing population. PLoS Genet 2012;8:
e1002629.
151. Grundberg E, Meduri E, Sandling JK et al. Global analysis of
DNA methylation variation in adipose tissue from twins reveals
links to disease-associated variants in distal regulatory ele-
ments. Am J HumGenet 2013;93:876–90.
152. Richmond RC, Simpkin AJ, Woodward G et al. Prenatal expo-
sure to maternal smoking and offspring DNA methylation
across the life course: findings from the Avon Longitudinal
Study of Parents and Children (ALSPAC). Hum Mol Genet
2015;24:2201–17.
153. Tsaprouni LG, Yang T-P, Bell J et al. Cigarette smoking reduces
DNA methylation levels at multiple genomic loci but the effect is
partially reversible upon cessation. Epigenetics 2014;9:1382–96.
154. Richmond RC, Sharp GC, Ward ME et al. DNA methylation
and BMI: investigating identified methylation sites at HIF3A in
a causal framework. Diabetes 2016;65:1231–44.
155. Leenen FAD, Muller CP, Turner JD. DNA methylation: con-
ducting the orchestra from exposure to phenotype? Clin
Epigenetics 2016;8:92.
International Journal of Epidemiology, 2018, Vol. 0, No. 0 27
Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyy153/5075855
by London School of Hygiene & Tropical Medicine user
on 28 August 2018
156. Schultz MD, He Y, Whitaker JW et al. Human body epigenome
maps reveal noncanonical DNA methylation variation. Nature
2015;523:212–16.
157. Cheung WA, Shao X, Morin A et al. Functional variation in al-
lelic methylomes underscores a strong genetic contribution and
reveals novel epigenetic alterations in the human epigenome.
Genome Biol 2017;18:50.
158. Campio´n J, Milagro FI, Martı´nez JA. Individuality and epige-
netics in obesity.Obes Rev 2009;10:383–92.
159. Preacher KJ. Advances in mediation analysis: a survey and synthe-
sis of new developments.Annu Rev Psychol 2015;66:825–52.
160. Li R, Tsaih S-W, Shockley K et al. Structural model analysis of
multiple quantitative traits. PLoS Genet 2006;2:e114.
161. Schadt EE, Lamb J, Yang X et al. An integrative genomics ap-
proach to infer causal associations between gene expression
and disease. Nat Genet 2005;37:710–17.
162. Millstein J, Zhang B, Zhu J, Schadt EE. Disentangling molecular
relationships with a causal inference test.BMCGenet 2009;10:23.
163. Relton CL, Davey Smith G. Two-step epigenetic Mendelian
randomization: a strategy for establishing the causal role of epi-
genetic processes in pathways to disease. Int J Epidemiol 2012;
41:161–76.
164. Yamada L, Chong S. Epigenetic studies in Developmental
Origins of Health and Disease: pitfalls and key considerations
for study design and interpretation. J Dev Orig Health Dis
2017;8:30–43.
165. Lin X, Barton S, Holbrook JD. How to make DNA methylome
wide association studies more powerful. Epigenomics 2016;8:
1117–29.
166. Munafo` MR, Davey Smith G. Repeating experiments is not
enough. Nature 2018;553:399–401.
167. Heijmans BT, Mill J. Commentary: the seven plagues of epige-
netic epidemiology. Int J Epidemiol 2012;41:74–78.
168. Mill J, Heijmans BT. From promises to practical strategies in
epigenetic epidemiology. Nat Rev Genet 2013;14:585–94.
169. Saffari A, Silver MJ, Zavattari P et al. Estimation of a signifi-
cance threshold for epigenome-wide association studies. Genet
Epidemiol 2018;42:20–33.
170. Kumaran K, Yajnik P, Lubree H et al. The Pune Rural
Intervention in Young Adolescents (PRIYA) study: design and
methods of a randomised controlled trial. BMC Nutr 2017;3:
41.
171. Potdar RD, Sahariah SA, Gandhi M et al. Improving women’s
diet quality preconceptionally and during gestation: effects on
birth weight and prevalence of low birth weight—a randomized
controlled efficacy trial in India (Mumbai Maternal Nutrition
Project). Am J Clin Nutr 2014;100:1257–68.
172. Owens S, Gulati R, Fulford AJ et al. Periconceptional multiple-
micronutrient supplementation and placental function in rural
Gambian women: a double-blind, randomized, placebo-
controlled trial. Am J Clin Nutr 2015;102:1450–59.
173. Nguyen PH, Young M, Gonzalez-Casanova I et al. Impact of
preconception micronutrient supplementation on anemia and
iron status during pregnancy and postpartum: a randomized
controlled trial in rural Vietnam.. PLoS One 2016;11:
e0167416.
174. Hambidge KM, Krebs NF, Westcott JE et al. Preconception ma-
ternal nutrition: a multi-site randomized controlled trial. BMC
Pregnancy Childbirth 2014;14:111.
175. Ladd-Acosta C, Fallin MD. The role of epigenetics in genetic
and environmental epidemiology. Epigenomics 2016;8:
271–83.
28 International Journal of Epidemiology, 2018, Vol. 0, No. 0
Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyy153/5075855
by London School of Hygiene & Tropical Medicine user
on 28 August 2018
